Finecare Anti-CCP (NEW) Rapid Quantitative Test Kit

The Finecare Anti-Cyclic Citrullinated Peptide (Anti-CCP) Rapid Quantitative Test Kit is an advanced fluorescence immunoassay designed for the quantitative measurement of antibodies against cyclic citrullinated peptides in human whole blood, serum and plasma. Manufactured by Wondfo, the test provides quantitative results within approximately 10 minutes when used with compatible Finecare Fluorescence Immunoassay (FIA) analyzers. Anti-CCP antibodies are important biomarkers associated with rheumatoid arthritis, a chronic autoimmune condition that affects the joints. Anti-CCP testing supports early clinical investigation, diagnosis and assessment of rheumatoid arthritis, particularly when used alongside rheumatoid factor (RF) testing and other clinical findings. The kit is suitable for hospitals, diagnostic laboratories, rheumatology clinics and other healthcare facilities requiring reliable autoimmune disease testing. Its fluorescence immunoassay technology, small sample requirement and convenient storage conditions make it an efficient solution for routine laboratory and point-of-care diagnostic applications. Key Features - Rapid Results: Delivers quantitative Anti-CCP results within approximately 10 minutes. - Quantitative Measurement: Measures Anti-CCP antibody concentrations from 3.5–300 U/mL. - Fluorescence Immunoassay Technology: Provides instrument-based quantitative antibody testing. - Multiple Sample Types: Supports human whole blood, serum and plasma. - Small Sample Volume: Requires approximately 10 µL of specimen. - Rheumatoid Arthritis Assessment: Supports the clinical investigation and diagnosis of rheumatoid arthritis. - Autoimmune Antibody Detection: Measures antibodies against cyclic citrullinated peptides. - Analyzer Compatibility: Works with compatible Finecare FIA analyzers. - Room-Temperature Storage: Stable between 4°C and 30°C. - Long Shelf Life: Up to 24 months under recommended storage conditions. - Professional Diagnostic Use: Suitable for hospitals, diagnostic laboratories and rheumatology clinics.